ARCHIVES

Trial Links Potential Biomarkers To Drugs For Lung Cancer, To Help Target Therapies

This article is from The Cancer Letter archive.

Vol. 33 No. 4 | April 30, 2010

Download PDF Visit The Full Archive

Related Articles

CMS also decided to cover off-label uses of approved colorectal cancer drugs in clinical trials, and allowed broader use of PET scans.

November 5, 2004

Funding Opportunities (12-page issue).

May 16, 2003

FDA Plans Greater Disclosures Over Wide Range Of Activities

May 21, 2010

Human Subject Rules Now Have forces Of Law; Already Conforming

June 7, 1974

Surgeons, Intramural Scientists Concerned About Representation

November 26, 1976

MicroRNA Biomarkers Linked To Early-Stage Prostate Cancer

February 24, 2012